ArticleF&S reports2026

Comments on "Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial".

Shashank Dokania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.